Synapse - Tumor epichaperome expression using (124)I PU-H71 PET (PU-PET) as a biomarker of response for PU-H71 plus nab-paclitaxel in HER2 negative (HER2-) metastatic breast cancer (MBC)

Tumor epichaperome expression using (124)I PU-H71 PET (PU-PET) as a biomarker of response for PU-H71 plus nab-paclitaxel in HER2 negative (HER2-) metastatic breast cancer (MBC) Meeting Abstract

Authors:	Jhaveri, K.; Dunphy, M.; Wang, R.; Comen, E.; Fornier, M.; Moynahan, M. E.; Bromberg, J.; Ma, W.; Patil, S.; Taldone, T.; Rodina, A.; Sterlin, V.; Khoshi, S.; Lewis, J.; Norton, L.; Chiosis, G.; Modi, S.
Abstract Title:	Tumor epichaperome expression using (124)I PU-H71 PET (PU-PET) as a biomarker of response for PU-H71 plus nab-paclitaxel in HER2 negative (HER2-) metastatic breast cancer (MBC)
Meeting Title:	41st Annual San Antonio Breast Cancer Symposium (SABCS)
Journal Title:	Cancer Research
Volume:	79
Issue:	4 Suppl.
Meeting Dates:	2018 Dec 4-10
Meeting Location:	San Antonio, TX
ISSN:	0008-5472
Publisher:	American Association for Cancer Research
Date Published:	2019-02-01
Language:	English
ACCESSION:	WOS:000478677002350
DOI:	10.1158/1538-7445.Sabcs18-p6-20-03
PROVIDER:	wos
Notes:	Meeting Abstract: P6-20-03 -- Source: Wos